XML 40 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restructuring and Asset Impairment Charges (Tables)
 3 Months Ended
Jun. 30, 2018
Restructuring and Related Activities [Abstract]  
Restructuring and Related Costs
Restructuring charges for our strategic growth initiative consisted of the following:
(In millions)
U.S. Pharmaceutical and Specialty Solutions
 
Medical-Surgical Solutions
 
Other
 
Total
Severance and employee-related costs, net
$
3

 
$
10

 
$
1

 
$
14

Exit-related costs (1)
1

 
2

 
21

 
24

Asset impairments and accelerated depreciation
4

 
—

 
16

 
20

Total
$
8

 
$
12

 
$
38

 
$
58

(1)    Exit-related costs primarily include lease exit costs associated with closures of retail pharmacy stores within our Canadian business.
Schedule of Restructuring and Asset Impairment Charges
The following table summarizes the activity related to the restructuring liabilities associated with the strategic growth initiative for the first quarter of 2019:
(In millions)
U.S. Pharmaceutical and Specialty Solutions
 
Medical-Surgical Solutions
 
Other
 
Total
Balance, March 31, 2018
$
—

 
$
—

 
$
—

 
$
—

Net restructuring charges recognized
8

 
12

 
38

 
58

Non-cash charges
(4
)
 
—

 
(16
)
 
(20
)
Cash payments
(1
)
 
—

 
—

 
(1
)
Balance, June 30, 2018
$
3

 
$
12

 
$
22

 
$
37